National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
J Addict Med. 2011 Sep;5(3):157-62. doi: 10.1097/ADM.0b013e31820497ae.
How do addiction treatment programs integrate the expectation of relapse into drug abuse treatment? This article serves as a thought piece to pose questions rather than definitive solutions. It reflects a distillation of discussions that occurred at the National Institute on Drug Abuse meeting titled "Program Response to Patient Relapse," held on July 15, 2009, along with quantitative and qualitative information about the patterns and types of discharge policies, which factors influence them, and how the culture of drug abuse treatment and the personnel interact with this issue. Some existing data on the discharging of relapsed patients are identified. A program's response to relapse is usually guided by its setting (level of care), philosophy (abstinence vs risk behavior reduction), and associated patient behavior ("benign" vs program disruptive). Key questions examined in this context include the following: Can different discharge policies impact a patient's access to treatment, and what are the implications of incorporating a medical model of addiction into discharge policies?
成瘾治疗项目如何将复发预期纳入药物滥用治疗？本文旨在提出问题，而非提供明确的解决方案。它反映了 2009 年 7 月 15 日举行的“国家药物滥用研究所会议”的讨论成果，该会议的标题为“项目对患者复发的反应”，其中包含了关于出院政策模式和类型、影响因素以及药物滥用治疗文化和人员如何与这一问题相互作用的定量和定性信息。本文还确定了一些有关复发患者出院的现有数据。项目对复发的反应通常由其环境（护理水平）、理念（戒除 vs 降低风险行为）以及相关的患者行为（“良性”与项目中断）决定。在此背景下，探讨的关键问题包括：不同的出院政策是否会影响患者获得治疗的机会，以及将成瘾的医学模式纳入出院政策会产生哪些影响？
